Sanchez Erika, Nicolini Humberto, Villatoro Jorge, Bustos Marycarmen, Medina-Mora María Elena, Mejía-Ortiz Paola, Robles Beatriz, Mondragón Diego, Ibarra Gema, Meza Daniela, Genis-Mendoza Alma Delia
Facultad de Ciencia y Tecnología, Universidad Simón Bolivar, Mexico City 03920, Mexico.
Laboratorio de Genómica de los Trastornos Psiquiátricos y Neurodegenerativos, Instituto Nacional de Medicina Genómica, Código Postal 14610, Mexico.
Int J Environ Res Public Health. 2025 Aug 2;22(8):1217. doi: 10.3390/ijerph22081217.
There is limited information on the prevalence of mental health symptoms among the population of Mexico City. To provide an update and determine the prevalence of symptoms associated with various disorders in the city, a modified version of the "Screener Questionnaire" was used, the same instrument employed in the National Survey on Drug, Alcohol, and Tobacco Use (ENCODAT) 2016-2017. Data were collected at PILARES centers in different boroughs of Mexico City. A total of 868 questionnaires on symptoms of psychiatric disorders and the use of drugs, alcohol, and tobacco were completed. The most frequently reported symptoms were anxiety (52.67%), depression (39.34%), and post-traumatic stress disorder (44.57%). Additionally, results showed alcohol use at 15.1%, followed by tobacco (13.6%) and illicit drug use (6.8%). The prevalence of these symptoms was also compared with data from ENCODAT 2016-2017 to observe changes over the years.
关于墨西哥城人口心理健康症状的患病率,现有信息有限。为了提供最新情况并确定该市各种疾病相关症状的患病率,使用了“筛查问卷”的修订版,该问卷与2016 - 2017年全国药物、酒精和烟草使用调查(ENCODAT)中使用的工具相同。数据在墨西哥城不同行政区的皮拉雷斯中心收集。总共完成了868份关于精神疾病症状以及药物、酒精和烟草使用情况的问卷。最常报告的症状是焦虑(52.67%)、抑郁(39.34%)和创伤后应激障碍(44.57%)。此外,结果显示酒精使用率为15.1%,其次是烟草(13.6%)和非法药物使用率(6.8%)。这些症状的患病率还与2016 - 2017年ENCODAT的数据进行了比较,以观察多年来的变化。